Interim Analysis from a Prospective Multicenter Study of Next-Generation Sequencing Minimal Residual Disease Assessment and CT Monitoring for Surveillance after Frontline Treatment in Diffuse Large B-Cell Lymphoma
Year: 2020
Type: article
Source: Blood
Authors: Anita Kumar, Jason Westin, Stephen J Schuster, Grzegorz S. Nowakowski, Izidore S. Lossos, Connie Lee Batlevi, Philip Caron, Pamela Drullinsky, John Gerecitano, Audrey Hamilton, Paul A. Hamlin, Steven M. Horwitz, Allison P. Jacob, Erel Joffe, Ashlee Joseph, Gottfried R. von Keudell, Leana Laraque, Oscar B Lahoud, Matthew J Matasar, Craig H. Moskowitz, Chelsea D Mullins, Ariela Noy, Colette Owens, Maria Lia Palomba, Carol S. Portlock, Ildefonso Rodriguez-Rivera, Gilles Salles, Venkatraman Seshan, David J. Straus, Shreya Vemuri, Anas Younes, Andrew D Zelenetz
Institutions: Memorial Sloan Kettering Cancer Center, The University of Texas MD Anderson Cancer Center, Abramson Cancer Center, University of Pennsylvania, Mayo Clinic, University of Miami, Sylvester Comprehensive Cancer Center, Johnson & Johnson (United States), Adaptive Biotechnologies (United States), University of Miami Health System
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3096867828